ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Amarantus Bioscience Holdings Inc (CE)

Amarantus Bioscience Holdings Inc (CE) (AMBS)

0,0001
0,00
(0,00%)
Fermé 10 Novembre 10:00PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,0001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
1 000
0,0001 Fourchette du Jour 0,0001
0,000001 Plage de 52 semaines 0,0401
Cap du marché
Clôture Veille
0,0001
Ouverture
0,0001
Dernière Transaction
1000
@
0.0001
Dernière heure de transaction
Volume financier
US$ 0
VWAP
0,0001
Volume moyen (3 m)
110 919
Actions en circulation
68 272 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-0,07
Chiffre d'affairess
95k
Bénéfice net
-4,76M

À propos de Amarantus Bioscience Holdings Inc (CE)

Amarantus Bioscience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases through its subsidiaries. AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative m... Amarantus Bioscience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases through its subsidiaries. AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by AMBS' wholly-owned subsidiary Cutanogen Corporation. AMBS' wholly-owned subsidiary MANF Therapeutics, Inc. owns key intellectual property rights and licenses from a number of prominent universities related to the development of the therapeutic protein known as mesencephalic astrocyte-derived neurotrophic factor ("MANF"). MANF Therapeutics, Inc. is developing MANF-based products as treatments for brain and ophthalmic disorders. MANF was discovered by the Company's Chief Scientific Officer John Commissiong, PhD. Dr. Commissiong discovered MANF from AMBS' proprietary discovery engine PhenoGuard. AMBS sold subsidiary Breakthrough Diagnostics to Todos Medical Ltd. in July of 2020. The Company also owns 51% of hemp/CBD company Hempori. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Carson City, Nevada, USA
Fondé
-
Amarantus Bioscience Holdings Inc (CE) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker AMBS. Le dernier cours de clôture d'Amarantus Bioscience (CE) était de US$0,00. Au cours de la dernière année, les actions de Amarantus Bioscience (CE) ont été négociées dans une fourchette de prix de US$ 0,000001 à US$ 0,0401.

Amarantus Bioscience (CE) compte actuellement 68 272 000 actions en circulation. La capitalisation boursière d'Amarantus Bioscience (CE) est de US$6 827,20 . Amarantus Bioscience (CE) a un ratio cours/bénéfice (ratio PE) de 0.00.

AMBS Dernières nouvelles

Todos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USA

Full US use of ANDiS 350 extraction systems would increase US daily testing capacity by 25% 3D Med extraction capacity increased by 1,000,000 kits per week Extraction reagent and automation...

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori    Strong customer retention at both stores in Dallas, TX with growing online presence  Focus...

Amarantus Provides 2019 Roadmap

  Amarantus Provides 2019 Roadmap   New York, NY -- January 7, 2019 -- InvestorsHub NewsWire -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the...

Coeptis Pharma Enters into Agreement to Acquire Elto Pharma

    Coeptis Pharma Enters into Agreement to Acquire Elto Pharma   New York, NY and Wexford, PA -- November 28, 2018 -- InvestorsHub NewsWire -- Coeptis...

Amarantus Provides Corporate Update

  Amarantus Provides Corporate Update   New York, NY -- July 20, 2018 -- InvestorsHub NewsWire -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the...

MANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published in

  MANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published in Peer-Reviewed Journal Experimental...

MANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal Model

  MANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal Model New York, NY -- June 11, 2018 -- InvestorsHub NewsWire...

Amarantus Provides Update on Elto Pharma Capital Formation Plan

  Amarantus Provides Update on Elto Pharma Capital Formation Plan   New York, NY -- June 07, 2018 -- InvestorsHub NewsWire --  Amarantus Bioscience Holdings, Inc...

MANF Therapeutics Announces Publication of Positive Data for MANF in Stroke Animal Model in AAAS Journal Science Advances

  MANF Therapeutics Announces Publication of Positive Data for MANF in Stroke Animal Model in AAAS Journal Science Advances   New York, NY USA -- June 05, 2018...

Amarantus Exercises Exclusive Option with Leipzig University for Alzheimer's Blood Diagnostic "LymPro Test 2.0"

Amarantus Exercises Exclusive Option with Leipzig University for Alzheimer's Blood Diagnostic "LymPro Test 2.0"   Scope of exercised Exclusive Option Agreement...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0001-500.00020.00020.00014630.00014417CS
4000.00010.000550.0001678080.00023691CS
129.9E-599001.0E-60.04011.0E-61109190.00016406CS
26000.00010.04011.0E-6788600.00015066CS
52-0.00055-84.61538461540.000650.04011.0E-67257020.00093364CS
156-0.0069-98.57142857140.0070.04011.0E-616885600.00372588CS
260-0.0139-99.28571428570.0140.04011.0E-614379470.00597001CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
OBCNObocon Inc (CE)
US$ 0,0002
(19 900,00%)
100
NNFCNanoforce Inc (CE)
US$ 0,0002
(19 900,00%)
100
AURIAuri Inc New (PK)
US$ 0,00015
(14 900,00%)
90,99M
CEVECeres Ventures Inc (CE)
US$ 0,0001
(9 900,00%)
207
TWOHTwo Hands Corporation (PK)
US$ 0,0001
(9 900,00%)
7,62M
SONXDSonendo Inc
 2,00
(-99,80%)
2,43k
IGOTFOMO Worldwide Inc (CE)
US$ 0,000001
(-99,50%)
13,49k
HLLPFHello Pal International Inc (CE)
US$ 0,000001
(-99,50%)
48,38k
REFGMedical Cannabis Payment Solutions (CE)
US$ 0,000001
(-99,00%)
2,8k
BLSPBlue Sphere Corporation (CE)
US$ 0,000001
(-99,00%)
601,99k
CGACCode Green Apparel Corp (PK)
US$ 0,0005
(400,00%)
773,64M
HMBLHUMBL Inc (PK)
US$ 0,0003
(0,00%)
228,82M
NSAVNet Savings Link Inc (PK)
US$ 0,0015
(172,73%)
224,69M
VIZCVizConnect Inc (PK)
US$ 0,0004
(14,29%)
194,29M
PSWWPrincipal Solar Inc (PK)
US$ 0,0003
(20,00%)
189,83M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock